Sign in
Home
Biz News
New Products
Cell Therapy
Medical Devices
Journal Papers
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, March 23, 2023
Sign in / Join
Contact
About
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Cell Tribune: Cell and Gene Therapy News and Research
Home
Biz News
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01 Study
New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
Sigilon Therapeutics approaches the clinic
New Products
CAR-T cell therapy benefits limited to few patients because of ‘Insurance Snags’
Helix BioPharma Corp. announces the signing of a non-binding letter of intent with ProMab Biotechnologies to develop cell based therapies
Cell Therapy
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
Sigilon Therapeutics approaches the clinic
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
Medical Devices
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity
Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia
Journal Papers
Immunotherapy gel targets lingering tumor cells after surgery
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in Cell citing reproducibility issues
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche
Business
Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene...
Cell Tribune
-
January 29, 2018
0
Business
CAR-T cell therapy benefits limited to few patients because of ‘Insurance...
Cell Tribune
-
January 11, 2018
0
Clinical Trials
GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of...
Cell Tribune
-
January 10, 2018
0
Business
GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells...
Cell Tribune
-
January 10, 2018
0
Cell Therapy
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
Cell Tribune
-
January 10, 2018
0
Business
Dynamk Capital Invests in FloDesign Sonics, a Game-Changer for Cell Therapy
Cell Tribune
-
January 10, 2018
0
Cell Therapy
FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical...
Cell Tribune
-
January 9, 2018
0
Cell Therapy
American CyroStem Warned by FDA to Stop Using Stem Cell Therapy...
Cell Tribune
-
January 9, 2018
0
Cell Therapy
Celixir’s cell therapy gets green light for heart failure trial
Cell Tribune
-
January 9, 2018
0
Immunotherapy
Cancer immune therapy developed from ‘miraculous’ recovery patients
Cell Tribune
-
November 24, 2017
0
1
2
3
4
...
8
Page 3 of 8
62
Followers
Follow
EDITOR PICKS
Cancer immune therapy developed from ‘miraculous’ recovery patients
Cell Tribune
-
November 24, 2017
Helix BioPharma Corp. announces the signing of a non-binding letter of intent with ProMab...
Cell Tribune
-
December 23, 2016
Healing wounds with cell therapy
Cell Tribune
-
May 29, 2017
STEMCELL Technologies Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology
Cell Tribune
-
December 22, 2016
